ARCHIVES

Tyrosine Kinase Inhibitor Encoraging For NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Budget Would Support 1,211 More Grants

February 7, 2003

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

In Brief: NCI May Support Studies Of Heat As Therapeutic Method DTIC OK Near for Malignant Melanoma

May 16, 1975

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011